These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 28926143

  • 1. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N, Garg N, Khankin EV, Cardarelli F, Pavlakis M.
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [Abstract] [Full Text] [Related]

  • 2. Outcomes following Kidney transplantation in IgA nephropathy: a UNOS/OPTN analysis.
    Kadiyala A, Mathew AT, Sachdeva M, Sison CP, Shah HH, Fishbane S, Jhaveri KD.
    Clin Transplant; 2015 Oct; 29(10):911-9. PubMed ID: 26190417
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of kidney transplantation in patients with IgA nephropathy based on induction: A UNOS data analysis.
    Aydin-Ghormoz EA, Perlmutter J, Koizumi N, Ortiz J, Faddoul G.
    Clin Transplant; 2024 Jan; 38(1):e15225. PubMed ID: 38127110
    [Abstract] [Full Text] [Related]

  • 4. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [Abstract] [Full Text] [Related]

  • 5. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC, Messina M, Fop F, Barreca A, Segoloni GP, Biancone L.
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [Abstract] [Full Text] [Related]

  • 7. Single-center long-term results of renal transplantation for IgA nephropathy.
    Bumgardner GL, Amend WC, Ascher NL, Vincenti FG.
    Transplantation; 1998 Apr 27; 65(8):1053-60. PubMed ID: 9583865
    [Abstract] [Full Text] [Related]

  • 8. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct 27; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 9. Renal transplantation in patients with primary immunoglobulin A nephropathy.
    Choy BY, Chan TM, Lo SK, Lo WK, Lai KN.
    Nephrol Dial Transplant; 2003 Nov 27; 18(11):2399-404. PubMed ID: 14551373
    [Abstract] [Full Text] [Related]

  • 10. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.
    Transpl Int; 2010 Feb 27; 23(2):169-75. PubMed ID: 19761553
    [Abstract] [Full Text] [Related]

  • 11. Alemtuzumab Induction and Steroid Minimization in IgA Nephropathy: A Matched-Cohort Analysis.
    Becker K, Brooks J, Mitro G, Rees M, Ortiz J.
    Exp Clin Transplant; 2020 Dec 27; 18(7):751-756. PubMed ID: 31875465
    [Abstract] [Full Text] [Related]

  • 12. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N.
    Clin Transplant; 2014 Aug 27; 28(8):845-54. PubMed ID: 24869763
    [Abstract] [Full Text] [Related]

  • 13. The clinical course of IgA nephropathy after kidney transplantation and its management.
    Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN.
    Transplant Rev (Orlando); 2017 Apr 27; 31(2):106-114. PubMed ID: 28209246
    [Abstract] [Full Text] [Related]

  • 14. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT, Pham PC.
    Nephrol Dial Transplant; 2012 Jul 27; 27(7):2965-71. PubMed ID: 22207327
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM, Marcus RJ, Ko TY, Nashar K, Thai NL, Sureshkumar KK.
    Exp Clin Transplant; 2016 Jun 27; 14(3):287-93. PubMed ID: 27221720
    [Abstract] [Full Text] [Related]

  • 16. The clinical outcomes of second kidney transplantation in IgA nephropathy: a multicenter retrospective study.
    Baek CH, Lee JG, Park JH, Kim H, Yang WS, Kim YS, Huh WS, Yang J, Han DJ, Park SK.
    Clin Nephrol; 2016 Aug 27; 86(2):87-93. PubMed ID: 27345187
    [Abstract] [Full Text] [Related]

  • 17. Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.
    Park S, Baek CH, Cho H, Yu MY, Kim YC, Go H, Kim YH, Lee JP, Min SI, Ha J, Moon KC, Kim YS, Ahn C, Park SK, Lee H.
    Am J Transplant; 2019 Jan 27; 19(1):145-155. PubMed ID: 29718591
    [Abstract] [Full Text] [Related]

  • 18. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Jan 27; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 19. Early steroid withdrawal results in improved patient and graft survival and lower risk of post-transplant cardiovascular risk profiles: A single-center 10-year experience.
    Lopez-Soler RI, Chan R, Martinolich J, Park L, Ata A, Chandolias N, Conti DJ.
    Clin Transplant; 2017 Feb 27; 31(2):. PubMed ID: 27888534
    [Abstract] [Full Text] [Related]

  • 20. Recurrence of IgA Nephropathy after Kidney Transplantation in Adults.
    Uffing A, Pérez-Saéz MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV.
    Clin J Am Soc Nephrol; 2021 Aug 27; 16(8):1247-1255. PubMed ID: 34362788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.